Our team of R&D professionals forges strong industrial and academic connections and collaborations to drive products from early clinical development to registration and reimbursement.
Mundipharma Research has a strong heritage of developing medicines for patients in pain and proven experience developing medicines for cancer and respiratory conditions.
Today, we’re focused on creating lasting partnerships to develop innovations that are at an early stage of their development; from pre-investigational new drug (IND) submission up to and including proof of concept (PoC).
Our current focus is treatments to address high unmet need in pain or the causes of pain. By leveraging a deep scientific understanding of relevant mechanisms in neuroscience and inflammation, we seek to see what others don’t and explore multiple potential development routes for new medicines.
Our expertise includes:
This expertise, combined with access to a network of external partners and the strengths of the Mundipharma global network of independent associated companies, enables us to progress opportunities through all stages of their development through to market.
Throughout the whole development process, the safety of patients is our key priority as we search for more innovative treatments for their unmet medical needs.
Press return to search